Psychopharmaceutical treatment for neurobehavioral problems in Duchenne muscular dystrophy: a descriptive study using real-world data.

MLA

Weerkamp, Pien M. M., et al. “Psychopharmaceutical Treatment for Neurobehavioral Problems in Duchenne Muscular Dystrophy: A Descriptive Study Using Real-World Data.” Neuromuscular Disorders : NMD, vol. 33, no. 7, July 2023, pp. 619–26. EBSCOhost, https://doi.org/10.1016/j.nmd.2023.05.011.

APA

Weerkamp, P. M. M., Geuens, S., Collin, P., Goemans, N., Vermeulen, R. J., De Waele, L., Hendriksen, J. G. M., & Klinkenberg, S. (2023). Psychopharmaceutical treatment for neurobehavioral problems in Duchenne muscular dystrophy: a descriptive study using real-world data. Neuromuscular Disorders : NMD, 33(7), 619–626. https://doi.org/10.1016/j.nmd.2023.05.011

Chicago

Weerkamp, Pien M M, Sam Geuens, Philippe Collin, Nathalie Goemans, R Jeroen Vermeulen, Liesbeth De Waele, Jos G M Hendriksen, and Sylvia Klinkenberg. 2023. “Psychopharmaceutical Treatment for Neurobehavioral Problems in Duchenne Muscular Dystrophy: A Descriptive Study Using Real-World Data.” Neuromuscular Disorders : NMD 33 (7): 619–26. doi:10.1016/j.nmd.2023.05.011.